When mass spectrometry redefines the pharma industry

In this new episode of omg OMx, Kate Stumpo speaks to Bruker’s Mike Greig about the incredible
potential of mass spectrometry in pharma.

Novo nabs over a third of diabetes market, a year ahead of schedule

Novo Nordisk’s GLP-1 drugs may have been the center of attention during its first-quarter earnings call, but the company’s broader diabetes portfolio beat its target

May 3, 2024

Hims & Hers Launches AI Service to Help Providers Personalize Treatments

[embedded content] What You Should Know: – Hims & Hers Health, the leading health and wellness platform, has unveiled MedMatch, an AI-powered solution designed to

November 7, 2023

Study explores adverse effects associated with psychotherapy

Psychotherapy is a key evidence-based method of treatment and rehabilitation for various mental health disorders, in addition to pharmacotherapy.

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.